Skip to Content

曾志偉 醫師

一, 06/03/2019 - 11:07 ( 最後修改時間 五, 2020-04-17 15:25 )

 

✦✦✦✦ 曾志偉 醫師 ✦✦✦✦

曾志偉醫師現在為本院肝膽胃腸科主任。

一個研究其實並不是單靠一位醫師就可以完成的，常常都是需要好幾位醫師共同合作才可以順利進行的。

曾醫師非常具有研究的精神，也非常樂意和別的醫師合作與分享研究的成果。我們柯的醫師們彼此間相處都非常融洽，這也就是為什麼他們可以完成許多傑出研究的最大原因。


✔治療專長：

治療性內視鏡、逆行性膽道攝影、內視鏡超音波、慢性肝炎治療

✔學歷：

陽明大學醫學系

✔經歷：

嘉義榮民醫院主治醫師

台北榮民總醫院胃腸肝研究醫師

台北榮民總醫院內科住院醫師

部定教職助理教授資格

✔現職：

內科部副主任

腸胃內科主任

✔研究： 

  1. Tseng KC, Ho YC, Tseng CW, Tseng LH, Hsieh YH, Chang TT, Wu SF. Decrease in regulatory T-cell function in chronic hepatitis C patients receiving pegylated-interferon plus ribavirin. Int J Infect Dis. 2017 May;58:8-17.
  2. Hung TH, Tseng CW, Tsai CC, Hsieh YH, Tseng KC, Tsai CC. Mortality Following Catheter Drainage Versus Thoracentesis in Cirrhotic Patients with Pleural Effusion. Dig Dis Sci. 2017 Apr;62(4):1080-1085.
  3. I-Tsang Chiang, Wei-Ting Chen, Chih-Wei Tseng , Yen-Chung Chen, Yu-Cheng Kuo, Bi-Jhih Chen, Mao-Chi Weng, Hwai-Jeng Lin , Wei-Shu Wang. Hyperforin Inhibits Cell Growth by Inducing Intrinsic and Extrinsic Apoptotic Pathways in Hepatocellular Carcinoma Cells. IT Chiang et al. Anticancer Res 37 (1), 161-167. 1 2017.
  4. Hung TH, Tseng CW, Tsai CC, Lay CJ, Tsai CC. A fourfold increase of oesophageal variceal bleeding in cirrhotic patients with a history of oesophageal variceal bleeding. Singapore Med J. 2016 Sep;57(9):511-3.
  5. Tseng KC, Tseng CW, Hsieh TY, Peng CY, Lin CL, Su TH, Tseng TC, Lin HH, Wang CC, Kao JH. Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues. Hepatol Res. 2016 Jun;46(7):642-9.
  6. Hung TH, Tsai CC, Tseng KC, Tseng CW, Hsieh YH, Tsai CC, Lee HF. High Mortality of Cirrhotic Patients With End-Stage Renal Disease. Medicine (Baltimore). 2016 Mar;95(10):e3057.
  7. Hung TH, Tsai CC, TsenK GC, Hsieh YH, Tseng CW. No mortality difference following treatment with terlipressin or somatostatin in cirrhotic patients with gastric variceal hemorrhage. Saudi J Gastroenterol. 2016 May-Jun;22(3):220-5.
  8. Chih-Wei Tseng, Ting-Tsung Chang, Shinn-Jia Tzeng, Yu-Hsi Hsieh, Tsung-Hsing Hung, Hsiang-Ting Huang, Shu-Fen Wu, and Kuo-Chih Tseng. Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C. Clin Interv Aging. 2016; 11: 327–334.
  9. Chih-Wei Tseng, Yen-Chun Chen. Recurrent abdominal pain after an episode of acute diverticulitis.               Advances in Digestive Medicine Volume 2, Issue 3, September 2015, Pages 119-120.
  10. Hung TH, Hsieh YH, Tseng KC, Tseng CW, Lee HF, Tsai CC, Tsai CC. High mortality in cirrhotic patients following hemorrhagic stroke. J Clin Neurosci. 2015 Jun;22(6):995-7.
  11. Hung TH, Lay CJ, Tseng CW, Tsai CC, Tsai CC. The effect of tuberculosis on the mortality of cirrhotic patients: a population-based 3-year follow-up study. Medicine (Baltimore). 2014 Dec;93(28):e295.
  12. Hung TH, Tseng CW, Tseng KC, Hsieh YH, Tsai CC, Tsai CC. Is end stage renal disease a risk factor for the mortality of cirrhotic patients with esophageal variceal bleeding? Hepatogastroenterology. 2014 Oct;61(135):1871-5.
  13. Hung TH, Tseng CW, Tseng KC, Hsieh YH, Tsai CC, Tsai CC. Effect of renal function impairment on the mortality of cirrhotic patients with hepatic encephalopathy: a population-based 3-year follow-up study. Medicine (Baltimore). 2014 Sep;93(14):e79.
  14. Chen JH, Lee CH, Tseng CW. A female patient with persistent epigastric pain for 1 week. Gastroenterology. 2014 Sep;147(3):e5-6.
  15. Hung TH, Tsai CC, Tsai CC, Tseng CW, Hsieh YH. Liver cirrhosis as a real risk factor for necrotising fasciitis: a three-year population-based follow-up study. Singapore Med J. 2014 Jul;55(7):378-82.
  16. Chih-Wei Tseng, Chi-Yi Chen, Ting-Tsung Chang, Shinn-Jia Tzeng, Yu-Hsi Hsieh, Tsung-Hsing Hung, Ching-Chih Lee, Shu-Fen Wu, and Kuo-Chih Tseng. Peginterferon Alfa-2a Is Associated with Elevations in Alanine Aminotransferase at the End of Treatment in Chronic Hepatitis C Patients with Sustained Virologic Response. PLoS One. 2014; 9(6): e100207.
  17. Tseng KC, Tseng CW, Hsieh YH, Chang CK, Lai NS, Hung TH, Chang TT. Effect of human leukocyte antigen class I and II alleles on hepatitis C viral load among chronic hepatitis C patients in Southern Taiwan. Hum Immunol. 2013 Aug;74(8):978-82.
  18. Tseng KC, Chou JL, Huang HB, Tseng CW, Wu SF, Chan MW. SOCS-1 promoter methylation and treatment response in chronic hepatitis C patients receiving pegylated-interferon/ribavirin. J Clin Immunol. 2013 Aug;33(6):1110-6.
  19. Hsieh YH, Lin HJ, Hsieh JJ, Tseng KC, Tseng CW, Hung TH, Leung FW. Meperidine as the single sedative agent during esophagogastroduodenoscopy, a double-blind, randomized, controlled study. J Gastroenterol Hepatol. 2013 Jul;28(7):1167-73.
  20. Ping-Hung Ko, Tsung-Hsing Hung, Chih-Wei Tseng. Severe Abdominal Pain 2 Days After Endoscopic Treatment. Gastroenterology. June 2013 Volume 144, Issue 7, Pages 1356, 1579.
  21. Hung TH, Tsai CC, Hsieh YH, Tsai CC, Tseng CW, Tsai JJ. Effect of renal impairment on mortality of patients with cirrhosis and spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol. 2012 Jun;10(6):677-81.
  22. Tsung-Hsing Hung, Chih-Wei Tseng, Yu-Hsi Hsieh, Kuo-Chih Tseng, Chih-Chun Tsai and Chen-Chi Tsai. High mortality of pneumonia in cirrhotic patients with ascites. BMC Gastroenterology. 201313:25.
  23. C-W Tseng, Y-H Hsieh, C-K Chang, N-S Lai, T-H Hung, S-F Wu, K-C Tseng. HLA-B*15:02 Is Associated With Anemia in Patients With Chronic Hepatitis C Treated With Pegylated Interferon-α and Ribavirin. Tissue Antigens. 80 (5), 424-430. 2012 Aug 30.

Share this


Theme by Dr. Radut.